Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Kilicarslan, T. Articles by Sellers, E. M. Search for Related Content PubMed Citation Articles by Kilicarslan, T. Articles by Sellers, E. M. Anxiolytics Molecular Biology

Lack of Interaction of Buprenorphine With Flunitrazepam Metabolism

OBJECTIVE: The authors’ goal was to determine if the reported clinical adverse interaction of flunitrazepam and buprenorphine was caused by inhibition of drug metabolism.METHOD: Inhibition of flunitrazepam metabolism by buprenorphine and norbuprenorphine were determined in three human liver microsome preparations carrying the CYP2C19*1/*1 allele. Omeprazole metabolism mediated by CYP2C19 and CYP3A4 was used as a control reaction. Apparent K_i values were determined.RESULTS: Norbuprenorphine did not inhibit the metabolism of flunitrazepam or omeprazole. Buprenorphine inhibited the formation of CYP3A4-mediated pathways of 3-hydroxyflunitrazepam and omeprazole sulfone formation (K_i 118 and 16 µM) in human liver microsomes. Corresponding values were 38 and 90 µM in cDNA-expressed CYP3A4 microsomes. Projected in vivo inhibition of CYP3A4-mediated metabolism of flunitrazepam by buprenorphine is 0.1%–2.5%. Estimated inhibition of buprenorphine N-dealkylation by flunitrazepam in vivo is 0.08%.CONCLUSIONS: The clinical interaction of flunitrazepam and buprenorphine is likely based on a pharmacodynamic mechanism.

This article has been cited by other articles:

				N. Picard, T. Cresteil, N. Djebli, and P. Marquet IN VITRO METABOLISM STUDY OF BUPRENORPHINE: EVIDENCE FOR NEW METABOLIC PATHWAYS Drug Metab. Dispos., May 1, 2005; 33(5): 689 - 695. [Abstract] [Full Text] [PDF]

				P. N. Gueye, S. W. Borron, P. Risede, C. Monier, F. Buneaux, M. Debray, and F. J. Baud Buprenorphine and Midazolam Act in Combination to Depress Respiration in Rats Toxicol. Sci., January 1, 2002; 65(1): 107 - 114. [Abstract] [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2000 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us